Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Lowered to $8.00 at Lake Street Capital

Bioceres Crop Solutions (NASDAQ:BIOX) had its price objective decreased by Lake Street Capital from $13.00 to $8.00 in a research report report published on Friday morning,Benzinga reports. Lake Street Capital currently has a buy rating on the stock.

Several other research firms have also weighed in on BIOX. Oppenheimer decreased their target price on shares of Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating on the stock in a report on Tuesday, January 28th. Canaccord Genuity Group lowered their price objective on Bioceres Crop Solutions from $9.50 to $7.00 and set a “buy” rating for the company in a research report on Friday. Four equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $10.00.

Bioceres Crop Solutions Price Performance

BIOX stock opened at $5.55 on Friday. Bioceres Crop Solutions has a 1 year low of $5.50 and a 1 year high of $14.05. The firm has a market capitalization of $348.04 million, a PE ratio of 277.64 and a beta of 0.57. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.27 and a quick ratio of 0.87. The business has a 50 day simple moving average of $6.65 and a 200-day simple moving average of $7.86.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its earnings results on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). The company had revenue of $92.60 million during the quarter, compared to analyst estimates of $117.15 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. During the same period last year, the business earned ($0.07) earnings per share. Equities research analysts anticipate that Bioceres Crop Solutions will post 0.12 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Bioceres Crop Solutions

Several large investors have recently made changes to their positions in the stock. Ping Capital Management Inc. raised its position in Bioceres Crop Solutions by 7.3% in the fourth quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock valued at $268,000 after purchasing an additional 3,000 shares during the period. Stifel Financial Corp grew its stake in shares of Bioceres Crop Solutions by 33.4% in the third quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock valued at $321,000 after buying an additional 10,224 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Bioceres Crop Solutions by 9.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after buying an additional 5,341 shares during the period. JPMorgan Chase & Co. lifted its stake in Bioceres Crop Solutions by 49.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock worth $708,000 after acquiring an additional 29,693 shares in the last quarter. Finally, Fourth Sail Capital LP boosted its holdings in Bioceres Crop Solutions by 16.6% during the 4th quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company’s stock valued at $22,490,000 after acquiring an additional 527,859 shares during the period. 17.68% of the stock is currently owned by institutional investors and hedge funds.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.